Home » Topics » BioWorld Science

BioWorld Science
RSS

Positive outcome of interim analysis of STRIDE-1 study of AXS-05

April 27, 2018

Achaogen receives funds to support development of aminoglycoside antibiotics

April 27, 2018

Orion Pharma enrolls participants in first-in-human study of ODM-208

April 27, 2018

Duke University patents mitochondrial antiviral-signaling protein compositions

April 27, 2018

Patient recruitment ongoing in phase II/III trial of relatlimab plus nivolumab in melanoma

April 27, 2018

Researchers present gene therapy for methamphetamine-induced inflammation

April 27, 2018

Phase I/II results for DS-5141 in patients with DMD

April 26, 2018

Interim phase II results encouraging for tropifexor in primary biliary cirrhosis

April 26, 2018

AveXis initiates phase III SPRINT trial of AVXS-101 in presymptomatic patients with SMA

April 26, 2018

Zealand holds end-of-phase II meeting with FDA on glepaglutide for short bowel syndrome

April 26, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...